Enzymotec Ltd. (ENZY) reported first quarter non-GAAP EPS of $0.24 Wednesday morning, compared to $0.12 last year. Analysts expected EPS of $0.17. The company now expects full year 2014 non-GAAP EPS of $0.64 to $0.94. The consensus estimate is for EPS of $0.86.
Enzymotec gapped open lower Wednesday and has spiked to the downside in early trade. The stock is currently lower by 4.73 at $15.50 and has plunged to over a 7-month low.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.